Stay updated on Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Sign up to get notified when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.

Latest updates to the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page
- Check5 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check12 days agoChange DetectedThe footer revision marker changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe study record page now displays a 403 Forbidden error, indicating access to the content is blocked. This replaces the typical study details with an access-denied notice rather than updating core content.SummaryDifference23%

- Check40 days agoChange DetectedThe study page text remains unchanged. Observed differences appear to be visual/layout updates that do not affect the core study details or results.SummaryDifference0.1%

- Check47 days agoChange DetectedThere are no recorded changes to the page content; the study details page remains unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedA new note indicates 2018 NIH grant/contract funding was added, and the page revision tag was updated to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

Stay in the know with updates to Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 2 Study of CPI-0610 Combo in Myelofibrosis Clinical Trial page.